CN1313769A - 含有COX－2抑制剂和iNOS抑制剂的药物组合 - Google Patents

含有COX－2抑制剂和iNOS抑制剂的药物组合 Download PDF

Info

Publication number
CN1313769A
CN1313769A CN99810007A CN99810007A CN1313769A CN 1313769 A CN1313769 A CN 1313769A CN 99810007 A CN99810007 A CN 99810007A CN 99810007 A CN99810007 A CN 99810007A CN 1313769 A CN1313769 A CN 1313769A
Authority
CN
China
Prior art keywords
piperidine
quinazoline
amine
spiro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99810007A
Other languages
English (en)
Chinese (zh)
Inventor
P·哈姆利
A·廷克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1313769A publication Critical patent/CN1313769A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN99810007A 1998-06-29 1999-06-23 含有COX－2抑制剂和iNOS抑制剂的药物组合 Pending CN1313769A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802333-6 1998-06-29
SE9802333A SE9802333D0 (sv) 1998-06-29 1998-06-29 Novel combination

Publications (1)

Publication Number Publication Date
CN1313769A true CN1313769A (zh) 2001-09-19

Family

ID=20411898

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99810007A Pending CN1313769A (zh) 1998-06-29 1999-06-23 含有COX－2抑制剂和iNOS抑制剂的药物组合

Country Status (22)

Country Link
US (1) US6248745B1 (enExample)
EP (1) EP1100505A1 (enExample)
JP (1) JP2002519324A (enExample)
KR (1) KR20010053252A (enExample)
CN (1) CN1313769A (enExample)
AU (1) AU4944799A (enExample)
BR (1) BR9911666A (enExample)
CA (1) CA2334515A1 (enExample)
CZ (1) CZ20004896A3 (enExample)
EE (1) EE200000766A (enExample)
ID (1) ID27394A (enExample)
IL (1) IL140022A0 (enExample)
IN (1) IN2000MU00721A (enExample)
IS (1) IS5794A (enExample)
MX (1) MXPA00012162A (enExample)
NO (1) NO20006559L (enExample)
PL (1) PL345028A1 (enExample)
SE (1) SE9802333D0 (enExample)
SK (1) SK18482000A3 (enExample)
TR (1) TR200003808T2 (enExample)
WO (1) WO2000000200A1 (enExample)
ZA (1) ZA200007076B (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004500358A (ja) * 1999-12-08 2004-01-08 ファルマシア　コーポレイション バイオアベイラビリティーが増加した固体状態のセレコキシブ
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
CA2432642A1 (en) * 2000-12-21 2002-08-08 Subhash P. Khanapure Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
AU2003207453A1 (en) * 2002-01-07 2003-07-24 Pharmacia Corp Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
US20040077691A1 (en) * 2002-06-21 2004-04-22 Medinox, Inc. Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
WO2004019986A1 (en) * 2002-08-29 2004-03-11 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
ES2537898T3 (es) 2005-10-25 2015-06-15 Shionogi & Co., Ltd. Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
WO2008049376A1 (en) 2006-10-25 2008-05-02 Huawei Technologies Co., Ltd. Processing location update request method, network entity, congestion control method and apparatus
CN101626787A (zh) * 2007-01-19 2010-01-13 马林克罗特公司 诊断的和治疗的环氧合酶-2结合配体
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
AU2008245082B8 (en) 2007-04-24 2012-09-13 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
CA2716628A1 (en) * 2008-03-24 2009-10-01 Carolus Therapeutics, Inc. Methods and compositions for treating atherosclerosis and related conditions
US8637504B2 (en) 2008-06-13 2014-01-28 Shionogi & Co., Ltd. Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
WO2010047372A1 (ja) 2008-10-22 2010-04-29 塩野義製薬株式会社 Ｂａｃｅ１阻害活性を有する２－アミノピリミジン－４－オンおよび２－アミノピリジン誘導体
US8453441B2 (en) 2008-11-06 2013-06-04 Purdue Research Foundation System and method for pump-controlled cylinder cushioning
MY145791A (en) * 2009-05-25 2012-04-30 Liang Woon San A method for producing a nutraceutical composition and the nutraceutical produced by the method
RU2012129168A (ru) 2009-12-11 2014-01-20 Сионоги Энд Ко. Лтд. Производные оксазина
WO2011077726A1 (ja) * 2009-12-24 2011-06-30 塩野義製薬株式会社 ４－アミノ－１，３－チアジンまたはオキサジン誘導体
ES2575917T3 (es) 2010-01-13 2016-07-04 Basf Se Nuevas variantes de mananasa
EP2545181B1 (en) 2010-03-12 2014-11-12 Council Of Scientific & Industrial Research Process for the production of violacein and its derivative deoxyviolacein containing bioactive pigment from chromobacterium sp. (mtcc 5522)
DE102010030500A1 (de) 2010-06-24 2011-12-29 Heliatek Gmbh Verdampfbares organisch halbleitendes Material und dessen Verwendung in einem optoelektronischen Bauelement
CA2816285A1 (en) 2010-10-29 2012-05-03 Shionogi & Co., Ltd. Naphthyridine derivative
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
DE102011018604A1 (de) 2011-04-25 2014-02-13 Michael Friebe Medikamenteninfusor für die Anwendung in stark magnetischen Umgebungen
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
EP2713937A1 (de) 2011-06-01 2014-04-09 Josef Schweiger Verbundkrone/verbundbrücke und verfahren zu deren herstellung
KR102128957B1 (ko) 2011-10-07 2020-07-02 론자 리미티드 조절가능한 프로모터
DE102012201426A1 (de) 2012-02-01 2013-08-01 Leibniz-Institut Für Polymerforschung Dresden E.V. Verfahren zum verbinden von kunststoffen und verfahren zum lösen einer verbindung im kunststoffverbund und kunststoffverbund
DE102012007141A1 (de) 2012-04-10 2013-10-10 Bernhard Spindler Jalousierbarer Rollladenpanzer
DE102012106428A1 (de) 2012-07-17 2014-01-23 Reha Technology GmbH Vorrichtung zur therapeutischen Behandlung, System zur gerätegestützten Lokomotionstherapie und Verfahren zur Steuerung der Vorrichtung
WO2014024034A1 (es) 2012-08-08 2014-02-13 Choque Alberto Pati Compostaje de residuos sólidos, liquidos y lodos biodegradables mediante humus de lombriz (eisenia foetida y especies similares) y mezclas de humus de lombriz y material estomacal con alto contenido de microrganismos
DE102012214452B4 (de) 2012-08-14 2019-08-01 Henkel Ag & Co. Kgaa Vorrichtung zum Auftragen einer fadenförmigen Masse
DE102012016116A1 (de) 2012-08-15 2014-02-20 Josip Fellner 360° Bag ln Box Spendersystem
DE102012214554A1 (de) 2012-08-16 2014-02-20 Robert Bosch Gmbh Verfahren zur Überführung von Batterien in einen entladenen Zustand, Batteriemanagementsystem, Inverter, System zur Erzeugung einer Wechselspannung, Ladestromquelle und Kraftfahrzeug
DE102012108153A1 (de) 2012-09-03 2014-03-06 Ludwig-Maximilians-Universität München Rohling und Verfahren zur Herstellung einer Dentalrestauration durch substraktive Bearbeitung
JP2016501827A (ja) 2012-10-24 2016-01-21 塩野義製薬株式会社 Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
DE102012112186A1 (de) 2012-12-12 2014-06-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Materialverbund, Verfahren zu dessen Herstellung, daraus hergestelltes System und Anwendung desselben
EP2956041A2 (de) 2013-02-15 2015-12-23 Jochen Mertens Mixer mit massnahmen zur reduzierung des eintrages von luftsauerstoff in den mixer-inhalt
DE102013101712B4 (de) 2013-02-21 2020-05-28 Heliatek Gmbh Photoaktives organisches Material für optoelektronische Bauelemente
DE102013101713B4 (de) 2013-02-21 2020-10-01 Heliatek Gmbh Photoaktives, organisches Material für optoelektronische Bauelemente
DE102013102366A1 (de) 2013-03-10 2014-09-11 Informium Ag Vorrichtungen zur Herstellung und zum Auslesen eines Identifikationsmerkmals mit integriertem Kopierschutz
DE102013102365A1 (de) 2013-03-10 2014-09-11 Informium Ag Identifikationsmerkmal mit integriertem Kopierschutz
DE102013102364A1 (de) 2013-03-10 2014-09-11 Informium Ag Verfahren zur Herstellung eines Identifikationsmerkmals mit integriertem Kopierschutz
DE102013004288A1 (de) 2013-03-13 2014-09-18 Matthias Lietzau Fahrzeug Verbindungsfolie
DE202013002767U1 (de) 2013-03-22 2013-05-28 Lorenz-Montagesysteme Gmbh Ausgleichende Seitverbindung von Solarmodulen
DE102013005741B3 (de) 2013-04-05 2014-05-22 IOT - Innovative Oberflächentechnologien GmbH Vorrichtung zur Inertisierung bei UV-Bestrahlung in offenen Durchlaufanlagen
EP2792394B1 (de) 2013-04-16 2016-07-27 Jörg Beutler Interaktive Geschwindigkeitssteuerung
DE102013104501A1 (de) 2013-05-02 2014-11-06 B. Braun Avitum Ag Vorrichtung zur extrakorporalen Blutbehandlung
DE102013008359A1 (de) 2013-05-16 2014-11-20 Sew-Eurodrive Gmbh & Co Kg Energiespeicher, der aus in Reihe geschalten Energiespeicherzellen aufgebaut ist, und Schaltungsanordnung zur passiven Symmetrierung einer Reihenschaltung von Kondensatoren
DE102013008919B4 (de) 2013-05-24 2017-12-07 Magdeburger Windkraftanlagen GmbH Rotorsystem für die Energiewandlung von kinetischer Energie in Fluiden und Massenströmen
DE202013006258U1 (de) 2013-07-11 2013-10-11 IMM Ingenieurbüro GmbH Vorrichtung zum Erzeugen von heizbaren Flächen mit homogener Wärmeverteilung
DE102013110693B4 (de) 2013-09-27 2024-04-25 Heliatek Gmbh Photoaktives, organisches Material für optoelektronische Bauelemente
EP2873807A1 (de) 2013-11-18 2015-05-20 Siemens Aktiengesellschaft Abdeckplatte, Laufschaufel, Radscheibe, Bolzen und Gasturbine
EP3071392B1 (de) 2013-11-19 2019-09-25 Fraunhofer Gesellschaft zur Förderung der Angewand Verfahren zum verbinden von silikongummi mit einem substrat
EP2902692B1 (de) 2013-12-06 2017-10-25 MAGNA STEYR Engineering AG & Co KG Bauteil eines Tanksystems
DE202014100570U1 (de) 2014-02-10 2014-03-10 Schlaadt Plastics Gmbh Klappsystem zur Verbindung von Partikelschaumbauteilen mittels eines gegen Verlust gesicherten Steckelements
DE102014004280A1 (de) 2014-03-26 2015-10-01 Florian M. König Impulssignal-Erzeugungsvorrichtung für Zwecke der autonomen Batterieaufladung oder 120-/230-Volt-Lampenversorgung
DE202014003299U1 (de) 2014-04-14 2014-08-25 Antje Koss Stollenschuh mit Wechselstollensystem
DE202014004532U1 (de) 2014-05-28 2014-08-05 Hans-Dieter Cornelius Hygienevorlage
DE102015214637A1 (de) 2014-11-10 2016-05-12 Hermann Roth Vorrichtung zur Erzeugung eines alkaloidhaltigen Aerosols
DE102014017938A1 (de) 2014-12-05 2016-06-09 Florian M. König Trichter-turbinenartige Vorrichtung mit elektromagnetischer Rotationssteuerung von Flüssigkeits-Mischvorgängen
DE102015000003A1 (de) 2015-01-02 2016-07-07 Solukon Ingenieure GbR (vertretungsberechtigte Gesellschafter: Andreas Hartmann, 86391 Stadtbergen und Dominik Schmid, 86165 Augsburg) Baubehälter für Produktionsanlagen zur Herstellung von Bauteilen in Schichtbauverfahren
DE102015008129A1 (de) 2015-01-22 2016-07-28 Liebherr-Hausgeräte Lienz Gmbh Verfahren zur Bestimmung der Dämmeigenschaft einer Wandung eines wärmeisolierten Behältnisses
DE102015000887A1 (de) 2015-01-23 2016-07-28 Arnulf Deinzer Zahnreinigungsgerät mit ausfahrbaren Borsten
DE102015015877A1 (de) 2015-12-09 2017-06-14 Bayerisches Zentrum für angewandte Energieforschung, e.V. (ZAE Bayern) Optisch schaltendes Element
DE102016006696A1 (de) 2016-05-27 2017-11-30 Christoph Jaeger Flugautosystem
DE202016004226U1 (de) 2016-07-06 2016-11-11 Helmut Senkel Schienensystem mit verfahrbaren Verbrauchern
CN106279585A (zh) * 2016-08-26 2017-01-04 宁波圣达精工智能科技有限公司 一种阻燃智能密集书架的制备方法
CN108832306B (zh) * 2018-06-13 2023-11-03 中国科学院国家天文台 一种fast反射面中心孔柔性封堵结构

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9800116A (et) * 1995-10-17 1998-10-15 Astra Pharmaceuticals Limited Farmatseutiliselt aktiivsed kinasoliini ühendid

Also Published As

Publication number Publication date
JP2002519324A (ja) 2002-07-02
BR9911666A (pt) 2001-03-20
PL345028A1 (en) 2001-11-19
EP1100505A1 (en) 2001-05-23
IN2000MU00721A (enExample) 2005-03-18
EE200000766A (et) 2002-06-17
US6248745B1 (en) 2001-06-19
ID27394A (id) 2001-04-05
IL140022A0 (en) 2002-02-10
NO20006559L (no) 2001-02-28
MXPA00012162A (es) 2001-05-01
SK18482000A3 (sk) 2001-07-10
CA2334515A1 (en) 2000-01-06
ZA200007076B (en) 2002-02-28
TR200003808T2 (tr) 2001-06-21
WO2000000200A1 (en) 2000-01-06
SE9802333D0 (sv) 1998-06-29
AU4944799A (en) 2000-01-17
CZ20004896A3 (en) 2001-06-13
KR20010053252A (ko) 2001-06-25
IS5794A (is) 2000-12-27
NO20006559D0 (no) 2000-12-21

Similar Documents

Publication Publication Date Title
US6248745B1 (en) Pharmaceutical combination comprising a COX-2 inhibitor and a iNOS inhibitor
US6046191A (en) Combination
AU715380B2 (en) Pyrazolopyrimidines for treatment of neuronal and other disorders
CN103068801A (zh) 硫代乙酸盐化合物、组合物及其使用方法
WO2025157289A1 (zh) 包含prmt5抑制剂和krasg12c抑制剂的药物组合物
US8389736B2 (en) Compounds having activity in correcting mutant-CFTR processing and uses thereof
EP1765347A2 (en) Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
JP5378221B2 (ja) 非常に高い皮膚浸透率を有するオキシカム及び関連化合物の正荷電水溶性プロドラッグ
JP2016536350A (ja) キヌレニン−３−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法
US12310967B2 (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
AU2018219213A1 (en) Treatment of diabetes and associated metabolic conditions with epigenetic modulators
WO2009051910A1 (en) Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
CN107898803A (zh) 虫草素在制备降尿酸药物中的应用
BRPI0718199A2 (pt) Composição, e, métodos para estabilizar o ritmo da respiração de um mamífero, e para aumentar a ventilação por minuto no nível dos centros de controle respiratório do tronco cerebral no nucleus tractus solitarius de um indivíduo.
WO2025157286A1 (zh) 包含prmt5抑制剂和mat2a抑制剂的药物组合物
BRPI0709994A2 (pt) combinação de compostos orgánicos
KR20220012903A (ko) 알코올-유발성 피부 안면홍조의 치료 및 완화를 위한 조성물 및 방법
JP2006509720A (ja) 潰瘍治療用プロトンポンプ阻害剤としての環付加ピロール化合物
TW201818964A (zh) 使用色胺酸羥化酶抑制劑之方法
ES3062815T3 (en) Compositions for treating aging-associated impairments using ccr3-inhibitors
JP2010526149A (ja) 消化管がんの処置のためのｈｄａｃ阻害剤の使用
JP5142991B2 (ja) １−（３−クロロフェニル）−３−アルキルピペラジンを含む食欲障害治療用医薬組成物
US20110034531A1 (en) Use of hdac inhibitors for the treatment of melanoma
JP2009292827A (ja) 炎症治療薬の調製のためのミゾラスチンの使用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1071420

Country of ref document: HK